Biased signaling via serotonin 5-HT2A receptor: from structural aspects to in vitro and in vivo pharmacology
Open Access
- 5 July 2025
- journal article
- review article
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 15 (9) , 4438-4455
Abstract
No abstract availableKeywords
Funding Information
- Medical University of Lublin (DS33)
This publication has 156 references indexed in Scilit:
- 25CN‐NBOH: A Selective Agonist for in vitro and in vivo Investigations of the Serotonin 2A ReceptorChemMedChem, 2021
- Comparative analysis of palmitoylation sites of serotonin (5‐HT) receptors in vertebratesNeuropsychopharmacology Reports, 2018
- Calcium‐dependent activation of transglutaminase 2 by nanosecond pulsed electric fieldsFEBS Open Bio, 2017
- Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways2017
- Characterization of the head-twitch response induced by hallucinogens in micePsychopharmacology, 2013
- Head‐twitch response in rodents induced by the hallucinogen 2,5‐dimethoxy‐4‐iodoamphetamine: a comprehensive history, a re‐evaluation of mechanisms, and its utility as a modelDrug Testing and Analysis, 2012
- Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in ratsPsychopharmacology, 2009
- Re-evaluation of lisuride pharmacology: 5-hydroxytryptamine 1A receptor-mediated behavioral effects overlap its other properties in ratsPsychopharmacology, 2002
- 5‐HT2A receptors and their second messenger IP3 are only correlated in human brain and not in plateletsNeuroscience Research Communications, 1999
- [3H]MDL 100,907: a novel selective 5-HT2A receptor ligandNaunyn-Schmiedeberg's Archives of Pharmacology, 1996